David A Potter

David A Potter is a Professor in the School of Medicine at the University of Minnesota, specializing in Hematology, Oncology, and Transplant Cellular Mechanisms of Cancer. His work focuses on Breast Cancer and related fields such as Clinical Trials, Immunology, and Chemotherapy.

• Email: dapotter@umn.edu

Research Interests: Potter’s research spans breast cancer pathobiology, immuno-oncology, and treatment optimization. He investigates neoadjuvant chemotherapy efficacy in relation to body mass index and explores endothelial dysfunction in survivors on aromatase inhibitors. His work also includes global health initiatives like virtual tumor boards in Mongolia.

Current Projects: Active studies include a Phase 3 trial of OP-1250 for advanced breast cancer, immune checkpoint blockade enhancement via epoxyeicosatrienoic acid inhibition, and platform trials like PRE-I-SPY for therapeutic response prediction. Collaborations involve pharmaceutical companies (AbbVie, Roche) and international institutions.

Scientific Impact: Potter’s work aligns with UN Sustainable Development Goals for healthcare innovation. His research outputs emphasize breast cancer, malignant neoplasms, and calpain mechanisms, with recent publications in high-impact journals like PNAS and Cardio-Oncology.